Andréasson B - Search Results

1

Survival and risk of vascular complications in myelofibrosis-A population-based study from the Swedish MPN group.

Lindgren M, Andréasson B, Samuelsson J, Pettersson H, Enblom-Larsson A, Ravn-Landtblom A, Scheding S, Bentham C, Ahlstrand E. Lindgren M, et al. Among authors: andreasson b. Eur J Haematol. 2022 Oct;109(4):336-342. doi: 10.1111/ejh.13813. Epub 2022 Jun 24. Eur J Haematol. 2022. PMID: 35696444

2

Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.

Andréasson B, Swolin B, Kutti J. Andréasson B, et al. Eur J Haematol. 2002 Apr;68(4):189-93. doi: 10.1034/j.1600-0609.2002.01610.x. Eur J Haematol. 2002. PMID: 12071933

3

Management of patients with polycythaemia vera: results of a survey among Swedish haematologists.

Andreasson B, Löfvenberg E, Westin J. Andreasson B, et al. Eur J Haematol. 2005 Jun;74(6):489-95. doi: 10.1111/j.1600-0609.2005.00424.x. Eur J Haematol. 2005. PMID: 15876252

4

AML transformation in 56 patients with Ph- MPD in two well defined populations.

Abdulkarim K, Girodon F, Johansson P, Maynadié M, Kutti J, Carli PM, Bovet E, Andréasson B. Abdulkarim K, et al. Among authors: andreasson b. Eur J Haematol. 2009 Feb;82(2):106-11. doi: 10.1111/j.1600-0609.2008.01163.x. Eur J Haematol. 2009. PMID: 19134023

5

[Polycythemia vera--focus on the Hb value. Future treatment can maybe result in disease remission].

Johansson P, Andreasson B, Samuelsson J. Johansson P, et al. Among authors: andreasson b. Lakartidningen. 2009 Jan 14-20;106(3):104-9. Lakartidningen. 2009. PMID: 19248459 Swedish. No abstract available.

6

[Essential thrombocytosis--a criteria diagnosis. Important to differentiate from reactive/secondary thrombocytosis].

Andreasson B, Johansson P, Samuelsson J. Andreasson B, et al. Lakartidningen. 2009 Jan 14-20;106(3):110-3. Lakartidningen. 2009. PMID: 19248460 Review. Swedish. No abstract available.

7

The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.

Abdulkarim K, Ridell B, Johansson P, Kutti J, Safai-Kutti S, Andréasson B. Abdulkarim K, et al. Among authors: andreasson b. Eur J Haematol. 2011 Feb;86(2):148-55. doi: 10.1111/j.1600-0609.2010.01548.x. Epub 2010 Dec 22. Eur J Haematol. 2011. PMID: 21059102

8

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.

Scherber R, Dueck AC, Johansson P, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferarri ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Harrison CN, Radia D, Mesa RA. Scherber R, et al. Among authors: andreasson b. Blood. 2011 Jul 14;118(2):401-8. doi: 10.1182/blood-2011-01-328955. Epub 2011 May 2. Blood. 2011. PMID: 21536863 Free article.

9

Björkholm M, Derolf AR, Hultcrantz M, Kristinsson SY, Ekstrand C, Goldin LR, Andreasson B, Birgegård G, Linder O, Malm C, Markevärn B, Nilsson L, Samuelsson J, Granath F, Landgren O. Björkholm M, et al. Among authors: andreasson b. J Clin Oncol. 2011 Jun 10;29(17):2410-5. doi: 10.1200/JCO.2011.34.7542. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537037 Free PMC article.

10

The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries.

Abelsson J, Merup M, Birgegård G, WeisBjerrum O, Brinch L, Brune M, Johansson P, Kauppila M, Lenhoff S, Liljeholm M, Malm C, Remes K, Vindelöv L, Andréasson B; Nordic MPD Study Group. Abelsson J, et al. Among authors: andreasson b. Bone Marrow Transplant. 2012 Mar;47(3):380-6. doi: 10.1038/bmt.2011.91. Epub 2011 May 9. Bone Marrow Transplant. 2012. PMID: 21552298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page